Home The effect of metformin on the metabolism of human vascular smooth muscle cells in high glucose conditions
Article
Licensed
Unlicensed Requires Authentication

The effect of metformin on the metabolism of human vascular smooth muscle cells in high glucose conditions

  • Ali Akbar Soleimani , Borhan Rahimi Abkenar , Nafiseh Shokri , Ghasem Ghasempour and Mohammad Najafi ORCID logo EMAIL logo
Published/Copyright: April 28, 2022

Abstract

Objectives

Metformin is widely used in type 2 diabetic patients as an antihyperglycemic drug. The aim of this study was to investigate the effect of metformin on the metabolism of vascular smooth muscle cells in high glucose conditions.

Materials and methods

The vascular smooth muscle cells were cultured in DMEM F12 containing glucose as high as 25 mM. The preconditioned cells were then treated with metformin in doses of 1, 5, and 7 mM for 24 h. MTT method was used to determine cell viability. Biochemical parameters including lactate, glucose, total protein, creatinine, and triglyceride were measured in the cell culture after the treatment with metformin. Oil Red O staining method was used to stain the lipids in the cells.

Results

Metformin reduced significantly (p<0.001) VSMC proliferation in a concentration-dependent manner. With the increase of glucose uptake by VSMCs, the cell lipid deposition was not changed. Other biochemical parameters such as lactate, triglyceride, total protein, and creatinine were significantly changed in the cell culture (p<0.05).

Conclusions

Metformin increased the glucose uptake impacting metabolic pathways in VSMCs. It also increased the lactate efflux and protein metabolism without the change in cellular lipid deposition in high glucose conditions.


Corresponding author: Mohammad Najafi, Clinical Biochemistry Department, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran, E-mail:

Award Identifier / Grant number: 1400-1-4-19363

  1. Research funding: This study was supported by the Iran University of Medical Sciences (1400-1-4-19363).

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript.

  3. Competing interests: The authors did not have any conflicts of interest.

  4. Informed consent: No applicable.

  5. Ethical approval: The study was approved by the Ethics Committee of Iran University of Medical Sciences (IR.IUMS.FMD.REC.1400.182).

References

1. Zhou, DM, Ran, F, Ni, HZ, Sun, LL, Xiao, L, Li, XQ, et al.. Metformin inhibits high glucose-induced smooth muscle cell proliferation and migration. Aging (Albany NY) 2020;12:5352–61. https://doi.org/10.18632/aging.102955.Search in Google Scholar PubMed PubMed Central

2. Yuan, T, Yang, T, Chen, H, Fu, D, Hu, Y, Wang, J, et al.. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol 2019;20:247–60. https://doi.org/10.1016/j.redox.2018.09.025.Search in Google Scholar PubMed PubMed Central

3. Byon, CH, Kim, SW. Regulatory effects of O-GlcNAcylation in vascular smooth muscle cells on diabetic vasculopathy. J Lipid Atheroscler 2020;9:243–54. https://doi.org/10.12997/jla.2020.9.2.243.Search in Google Scholar PubMed PubMed Central

4. Jeong, IK, Oh, DH, Park, SJ, Kang, JH, Kim, S, Lee, MS, et al.. Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Exp Mol Med 2011;43:684–92. https://doi.org/10.3858/emm.2011.43.12.079.Search in Google Scholar PubMed PubMed Central

5. Frismantiene, A, Philippova, M, Erne, P, Resink, TJ. Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity. Cell Signal 2018;52:48–64. https://doi.org/10.1016/j.cellsig.2018.08.019.Search in Google Scholar PubMed

6. Marx, SO, Totary-Jain, H, Marks, AR. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 2011;4:104–11. https://doi.org/10.1161/circinterventions.110.957332.Search in Google Scholar PubMed PubMed Central

7. Jeong, K, Kim, JH, Murphy, JM, Park, H, Kim, SJ, Rodriguez, YAR, et al.. Nuclear focal adhesion kinase controls vascular smooth muscle cell proliferation and neointimal hyperplasia through GATA4-mediated cyclin D1 transcription. Circ Res 2019;125:152–66. https://doi.org/10.1161/circresaha.118.314344.Search in Google Scholar PubMed PubMed Central

8. Foretz, M, Guigas, B, Bertrand, L, Pollak, M, Viollet, B. Metformin: from mechanisms of action to therapies. Cell Metab 2014;20:953–66. https://doi.org/10.1016/j.cmet.2014.09.018.Search in Google Scholar PubMed

9. American Diabetes, A. Standards of medical care in diabetes – 2014. Diabetes Care 2014;37(1 Suppl):S14. https://doi.org/10.2337/dc14-S014.Search in Google Scholar PubMed

10. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854–65.10.1016/S0140-6736(98)07037-8Search in Google Scholar

11. Natali, A, Ferrannini, E. Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. Diabetologia 2006;49:434–41. https://doi.org/10.1007/s00125-006-0141-7.Search in Google Scholar PubMed

12. Geerling, JJ, Boon, MR, van der Zon, GC, van den Berg, SA, van den Hoek, AM, Lombès, M, et al.. Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice. Diabetes 2014;63:880–91. https://doi.org/10.2337/db13-0194.Search in Google Scholar PubMed

13. Horman, S, Beauloye, C, Vanoverschelde, JL, Bertrand, L. AMP-activated protein kinase in the control of cardiac metabolism and remodeling. Curr Heart Fail Rep 2012;9:164–73. https://doi.org/10.1007/s11897-012-0102-z.Search in Google Scholar PubMed

14. Gundewar, S, Calvert, JW, Jha, S, Toedt-Pingel, I, Ji, SY, Nunez, D, et al.. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res 2009;104:403–11. https://doi.org/10.1161/circresaha.108.190918.Search in Google Scholar PubMed PubMed Central

15. Kennedy, L, Herman, WH. Renal status among patients using metformin in a primary care setting. Diabetes Care 2005;28:922–4. https://doi.org/10.2337/diacare.28.4.922.Search in Google Scholar PubMed

Received: 2022-01-20
Accepted: 2022-03-30
Published Online: 2022-04-28

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Peyronie’s disease: where are we at?
  4. Reviews
  5. Catheter-associated urinary tract infection: an overview
  6. Liver and heart failure: an ultrasound relationship
  7. Original Articles
  8. The intracellular fluid compartment is smaller than commonly believed when measured by whole-body bioimpedance
  9. Prevalence and distribution of causes of infertility according to women’s age – a cross-sectional study in a tertiary healthcare hospital setup
  10. Supplementation of antihypertensive drug regimen with vitamin E ameliorates alterations of primary haemodynamic parameters and total antioxidant capacity in ovariectomised rats
  11. Analgesic effect of curcumin topical formulation in knee osteoarthritis patients: a clinical trial
  12. ProACT in the management of stress urinary incontinence after radical prostatectomy. What happens after 8 years of follow up? monocentric analysis in 42 patients
  13. The effect of metformin on the metabolism of human vascular smooth muscle cells in high glucose conditions
  14. Physiological response of endurance exercise as a growth hormone mediator in adolescent women’s
  15. Effect of Om chanting and Yoga Nidra on depression anxiety stress, sleep quality and autonomic functions of hypertensive subjects – a randomized controlled trial
  16. Effectiveness of electrical vestibular nerve stimulation as adjunctive therapy to improve the cognitive functions in patients with Parkinson’s disease
  17. Role of interleukin-22 in tuberculosis patients
  18. Effect of aspirin on the TNF-α-mediated cell survival and death pathways in breast cancer
  19. Resting heart rate variability as a diagnostic marker of cardiovascular dysautonomia in postural tachycardia syndrome
  20. Effects of intensity and training on cardiovascular responses to the Valsalva maneouvre
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2022-0018/html
Scroll to top button